JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2008, Vol. 46 ›› Issue (12): 1158-1161.

• Articles • Previous Articles     Next Articles

Longterm use of Valproic acid inhibits the PC3 cell line growth in nude mice in vivo

 GAO De-Han, JIA Qing-Hua, LV Jia-Ju, ZHANG Hui   

  1. Department of Urology, Provincial Hospital Affiliated to Shandong University, Jinan 250021, China
  • Received:2007-12-24 Online:2008-12-16 Published:2009-12-16

Abstract:

Objective Valproic acid (VPA) is an established drug in the long-term therapy of seizure disorders. Recently, VPA has been associated with anticancer activity, an effect thought to be produced by inhibition of cellular histone deacetylase 1.  Methods  The PC3 cell line tumor xenografts was established. Animals in the experimental group were given 0.4% VPA in their drinking water until tumors reached 5 mm in the longest dimension. At the end of day 28, tumors were harvested, whole blood was collected and serum was analyzed for VPA, liver function tests (transaminases) and complete blood count. The DNA strand breaks were identified by the terminal deoxynucleotidyltransferasemediated UTP end labeling technique using the in situ Cell Death Detection Kit. Effects of VPA on histone acetylation and p21WAF/CIP gene expression were investigated by Western blot. Ki67 and p21WAF/CIP were detected by Immunohistochemistry in tissues of PC3 cell line tumor xenografts. ResultsChronic VPA treatment resulted in statistically significant reduction of tumor xenograft growth in vivo. Tumor volumes were measured and compared using the Wilcoxon ranksum test and 2way ANOVA with posthoc testing. Animals treated with VPA showed a statistically significant decrease in tumor volume compared with controls with 77.27% growth inhibition. Treatment of xenografts with VPA induced a significant increase in levels of acetylated histone H3 and p21WAF/CIP compared with the controls (P<0.01). In the VPA treated tumors, apoptotic cell death was markedly increased compared with the control tumors (P<0.01). Ki67 expression in the control group was stronger than in the experimental group (P<0.01). Conclusion  We conclude that chronic administration of VPA results in a significant reduction in PC3 cell line tumor xenograft volume in vivo. These data provide compelling evidence that additional studies are warranted in evaluating the potential use of chronic VPA as a means of altering androgen independent prostate cancer cell growth and progression.

Key words: Prostate tumor; Valproic acid; Proliferation; Apoptosis; Mice, nude

CLC Number: 

  • R737.25
[1] GAO Feng-bin, SI Man-fei, LIU Yong-qing, NIU Lei-lei, YUAN Hui-qing. Retigeric acid B induced cell cycle arrest in human prostate cancer cells by upregulation of p21CIP1 [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(12): 34-40.
[2] GUO Xiao-yu1, JIANG Yan2, XING Zhao-quan3, GUO Zhao-xin3, FANG Zhi-qing3, LIU Zhao-xu1,3. The effect of methyltransferase inhibitor on the expression of
XAF1 mRNA in prostate cancer
[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(12): 94-.
[3] ZHENG Gui-xi, WANG Chuan-xin, ZHANG Xin, LI Wei, DU Lu-tao, LI Juan, LIU Hui. Screening and biological characteristics study of human
single chain Fv antibody against prostatic cancer
[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(11): 34-38.
[4] XIAO Pan1, ZHANG Huai-qiang1, CUI Ya-zhou2, ZHAO Sheng-tian1, MA Tian-jia1, ZHOU Chun-wen1. A proteomics study of docetaxel-induced apoptosis in
prostate cancer PC3 cells
[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(10): 77-.
[5] HAN Bo1,3, YANG Xiao-qing1, ZHANG Jing2, LIU Wen-jun3, LIU Long3. Role of SPINK1 in prostate cancer: advances in experimental and
translational research
[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(8): 40-.
[6] WANG Hai-bin, MA Wei-ming, XIAO Pan, MA Tian-jia, ZHANG Huai-qiang. Differential  expressions of HSP60 in docetaxel treatment on
advanced hormone-resistant prostate cancer
[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(8): 46-50.
[7] YU Zhang-jian1, ZHANG Shi-bao1, LIU Qing-yong1, RUAN Xi-yun2, YANG Guang-xiao3, WANG Quan-ying3. Construction of a recombinant adenoassociated viral vector expressing SAC and its inhibition on CAM xenograft prostate cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(7): 41-.
[8] CHEN Zhao-bo, LIU Chun-yan, NI Na-na, YU Yang, ZHANG Peng-ju, CHEN Wei-wen, JIANG An-li. miR Let-7a1/f1 down-regulates AMD1 expression in prostate cancer LNCaP cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(1): 29-.
[9] ZHANG Shi-Bao, LIU Qing-Yong, RUAN Xi-Yun, CHEN Jie, ZHANG Jian-Jun, LI Zong-Wu, YANG Guang-Xiao, WANG Quan-Ying. onstruction and identification of the expression vector of
NT4-SAC-HA2-TAT fusion gene
[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 15-19.
[10] ZHANG Shi-Bao, LIU Qing-Yong, RUAN Xi-Yun, CHEN Jie, ZHANG Jian-Jun, LI Zong-Wu, YANG Guang-Xiao, WANG Quan-Ying. onstruction and identification of the expression vector ofNT4-SAC-HA2-TAT fusion gene [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2009, 47(6): 15-19.
[11] . Evaluation of androgendependent and androgenindependent 
proteome in LNCaP cells
[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2009, 47(9): 62-65.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!